摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methyl-1-[4-(pyridin-2-ylmethyl)piperidin-1-yl]propan-1-one

中文名称
——
中文别名
——
英文名称
2-Methyl-1-[4-(pyridin-2-ylmethyl)piperidin-1-yl]propan-1-one
英文别名
2-methyl-1-[4-(pyridin-2-ylmethyl)piperidin-1-yl]propan-1-one
2-Methyl-1-[4-(pyridin-2-ylmethyl)piperidin-1-yl]propan-1-one化学式
CAS
——
化学式
C15H22N2O
mdl
——
分子量
246.35
InChiKey
DWVWBITUVADOFB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    33.2
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • Therapeutic compounds and uses thereof
    申请人:GENENTECH, INC.
    公开号:US10258603B2
    公开(公告)日:2019-04-16
    The present invention relates to compounds of formula (I): and to salts thereof, wherein R1, R2, Rc, and Rd have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of bromodomains. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various bromodomain-mediated disorders.
    本发明涉及式(I)化合物: 及其盐,其中 R1、R2、Rc 和 Rd 具有说明书中定义的任意值,以及其组合物和用途。这些化合物可用作溴链的抑制剂。还包括包含式(I)化合物或其药学上可接受的盐的药物组合物,以及使用这种化合物和盐治疗各种溴链介导的疾病的方法。
  • THERAPEUTIC COMPOUNDS AND USES THEREOF
    申请人:GENENTECH, INC.
    公开号:US20170340604A1
    公开(公告)日:2017-11-30
    The present invention relates to compounds of formula (I): and to salts thereof, wherein R 1 , R 2 , R c , and R d have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of bromodomains. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various bromodomain-mediated disorders.
查看更多